NCT05330182

LMN-201 for Prevention of C. Difficile Infection Recurrence

RecruitingPHASE2, PHASE3INTERVENTIONAL

Trial Details

Start: 2024-08-29Est. Completion: 2026-08-31

Enrollment target: 375 participants

Locations

Kaiser Permanente, Escondido, California, United States
Gastroenterology Center of Connecticut, Hamden, Connecticut, United States
University of South Florida, Tampa, Florida, United States
Metro Infectious Disease Consultants, LLC, Burr Ridge, Illinois, United States
Baptist Health Research, Lexington, Kentucky, United States
Henry Ford Health System, Detroit, Michigan, United States
University of Minnesota, Minneapolis, Minnesota, United States
Mayo Clinic - Rochester, Rochester, Minnesota, United States
Weill Cornell Medicine, New York, New York, United States
IMA Clinical Research, Mount Airy, North Carolina, United States
MD Anderson Cancer Center, Houston, Texas, United States
Clinical Alliance for Infectious Diseases - Infectious Diseases, LLC, Annandale, Virginia, United States
University of Virginia School of Medicine, Charlottesville, Virginia, United States
Kaiser Permanente-Mid Atlantic, Springfield, Virginia, United States
UW Health University Hospital, Madison, Wisconsin, United States

Hemodialysis

The purpose of this study is to assess the efficacy of prophylactic antibiotic treatment on blood stream infections and …

Copenhagen, DenmarkEst. completion Oct 2028

Leukemia, Lymphocytic, AcuteLeukemia, Myeloid, AcuteLymphomaClostridium Difficile InfectionSolid Cancers

The primary objective of the study is to determine whether dietary intervention to increase fiber and decrease fat reduc…

Aurora, United StatesCompleted Jul 2, 2025

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.